Ngā hua rapu - Dearnaley, D
- E whakaatu ana i te 1 - 20 hua o te 62
- Haere ki te Whārangi Whai Ake
-
1
Cancer of the prostate. mā Dearnaley, D. P.
I whakaputaina 1994Text -
2
-
3
-
4
-
5
-
6
Small-cell carcinoma of the prostate. mā Nutting, C, Horwich, A, Fisher, C, Parsons, C, Dearnaley, D P
I whakaputaina 1997Text -
7
-
8
Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer mā Lemanska, A., Dearnaley, D.P., Jena, R., Sydes, M.R., Faithfull, S.
I whakaputaina 2018Text -
9
-
10
-
11
Accuracy and Reproducibility of Conformal Radiotherapy using Data from a Randomised Controlled Trial of Conformal Radiotherapy in Prostate Cancer (MRC RT01, ISRCTN47772397) mā Stanley, S., Griffiths, S., Sydes, M.R., Moore, A.R., Syndikus, I., Dearnaley, D.P.
I whakaputaina 2008Text -
12
-
13
Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer mā Parker, C C, Norman, A R, Huddart, R A, Horwich, A, Dearnaley, D P
I whakaputaina 2002Text -
14
-
15
-
16
Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer mā Ferreira, M.R., Thomas, K., Truelove, L., Khan, A., Parker, C., Dearnaley, D.P., Gulliford, S.
I whakaputaina 2019Text -
17
-
18
-
19
-
20
Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters mā Riches, S F, Payne, G S, deSouza, N M, Dearnaley, D, Morgan, V A, Morgan, S C, Partridge, M
I whakaputaina 2014Text